Filter
54
Text search:
L.
Mofenson
Featured
Recommendations
6
New Publications
3
Language
Document type
No document type
34
Guidelines
10
Studies & Reports
7
Manuals
3
Countries / Regions
Africa
3
Zimbabwe
2
Kenya
2
Thailand
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ethiopia
1
Cameroon
1
Uganda
1
Haiti
1
Zambia
1
Tanzania
1
Rwanda
1
Malawi
1
Eswatini/ Swaziland
1
Brazil
1
Lesotho
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Countries
4
Women & Child Health
2
Public Health
1
Toolboxes
HIV
40
TB
5
COVID-19
3
Mental Health
1
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven
...
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Accessed: 20.10.2019
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Journal of Infection and Public Health 12 (2019) 213–223
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021